KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 97 filers reported holding KURA ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,276,000 | -7.7% | 228,318 | +2.7% | 1.36% | +18.3% |
| Q2 2021 | $4,634,000 | -23.2% | 222,263 | +4.1% | 1.15% | -6.0% |
| Q1 2021 | $6,035,000 | +39.7% | 213,471 | +61.4% | 1.22% | +38.6% |
| Q4 2020 | $4,320,000 | +350.5% | 132,283 | +322.9% | 0.88% | +365.3% |
| Q3 2020 | $959,000 | +37.8% | 31,283 | -26.7% | 0.19% | -6.4% |
| Q2 2020 | $696,000 | -65.7% | 42,683 | -70.4% | 0.20% | -72.5% |
| Q4 2018 | $2,028,000 | -84.1% | 144,411 | -80.1% | 0.74% | -83.1% |
| Q3 2018 | $12,727,000 | -16.5% | 727,258 | -13.2% | 4.37% | -48.2% |
| Q2 2018 | $15,244,000 | +23.7% | 837,604 | +27.4% | 8.43% | +13.8% |
| Q1 2018 | $12,326,000 | +105.5% | 657,411 | +67.7% | 7.41% | +118.9% |
| Q4 2017 | $5,998,000 | +45.5% | 392,027 | +42.2% | 3.38% | +58.2% |
| Q3 2017 | $4,122,000 | – | 275,731 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |